Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan R Brody

Showing results (121-130 of 170) with videos related to

Pageof 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2018
STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA RepairCristina Maranto, Vindhya Udhane, David T Hoang, et al.
Cancer Research Communications|August 15, 2025
HuR-Regulated Extracellular Vesicles Promote Endothelial Cell Remodeling in Pancreatic CancerJennifer M Finan, Yifei Guo, Alexandra Q Bartlett, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Pancreatic cancer-intrinsic HuR regulates the pro-tumorigenic properties of extracellular vesiclesJennifer M Finan, Yifei Guo, Alexandra Q Bartlett, et al.
Molecular Cancer Research : MCR|August 7, 2019
Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 InhibitionTeena Dhir, Christopher W Schultz, Aditi Jain, et al.
Annals of Surgery|November 29, 2016
Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical TrialTalar Tatarian, Wei Jiang, Benjamin E Leiby, et al.
Cancer Biology & Therapy|November 8, 2024
The polymeric fluoropyrimidine CF10 overcomes limitations of 5-FU in pancreatic ductal adenocarcinoma cells through increased replication stressJennifer M Finan, Roberto Di Niro, Soon Young Park, et al.
Oncotarget|November 16, 2017
A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiativeMichael J Pishvaian, R Joseph Bender, Lynn M Matrisian, et al.
Surgical Oncology|June 21, 2020
A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution's experienceCinthya Y Lowder, Teena Dhir, Austin B Goetz, et al.
Genes, Chromosomes & Cancer|January 27, 2017
Alterations of type II classical cadherin, cadherin-10 (CDH10), is associated with pancreatic ductal adenocarcinomasNatini Jinawath, Meng-Shin Shiao, Alexis Norris, et al.
Molecular Cancer Research : MCR|April 8, 2016
HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer CellsCarmella Romeo, Matthew C Weber, Mahsa Zarei, et al.
Pageof 17

Showing results (121-130 of 170) with videos related to

Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2018
STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA RepairCristina Maranto, Vindhya Udhane, David T Hoang, et al.
Cancer Research Communications|August 15, 2025
HuR-Regulated Extracellular Vesicles Promote Endothelial Cell Remodeling in Pancreatic CancerJennifer M Finan, Yifei Guo, Alexandra Q Bartlett, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Pancreatic cancer-intrinsic HuR regulates the pro-tumorigenic properties of extracellular vesiclesJennifer M Finan, Yifei Guo, Alexandra Q Bartlett, et al.
Molecular Cancer Research : MCR|August 7, 2019
Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 InhibitionTeena Dhir, Christopher W Schultz, Aditi Jain, et al.
Annals of Surgery|November 29, 2016
Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical TrialTalar Tatarian, Wei Jiang, Benjamin E Leiby, et al.
Cancer Biology & Therapy|November 8, 2024
The polymeric fluoropyrimidine CF10 overcomes limitations of 5-FU in pancreatic ductal adenocarcinoma cells through increased replication stressJennifer M Finan, Roberto Di Niro, Soon Young Park, et al.
Oncotarget|November 16, 2017
A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiativeMichael J Pishvaian, R Joseph Bender, Lynn M Matrisian, et al.
Surgical Oncology|June 21, 2020
A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution's experienceCinthya Y Lowder, Teena Dhir, Austin B Goetz, et al.
Genes, Chromosomes & Cancer|January 27, 2017
Alterations of type II classical cadherin, cadherin-10 (CDH10), is associated with pancreatic ductal adenocarcinomasNatini Jinawath, Meng-Shin Shiao, Alexis Norris, et al.
Molecular Cancer Research : MCR|April 8, 2016
HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer CellsCarmella Romeo, Matthew C Weber, Mahsa Zarei, et al.
Pageof 17